# Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation

> **NCT03148002** · PHASE4 · COMPLETED · sponsor: **Nova Scotia Health Authority** · enrollment: 25 (actual)

## Conditions studied

- Constipation
- Peritoneal Dialysis Complication

## Interventions

- **DRUG:** Current Bowel Protocol (senna/lactulose)
- **DRUG:** PEG Bowel Protocol (PEG/lactulose)

## Key facts

- **NCT ID:** NCT03148002
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-07
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-06-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03148002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03148002, "Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03148002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*